KDM1A and colorectal carcinoma: Notably, despite pharmacological targeting of KDM1A showed no significant acute cytotoxicity in several CRC cell lines (Supplementary Fig. 1), KDM1A inhibitors, such as ORY-1001 and GSK2879552, reduced cell migration at a clinically relevant dose (Fig. 4H, I).